{"id":"W2889696398","doi":"10.1038/s41416-018-0261-0","title":"Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma","year":2018,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Pazopanib; Everolimus; Medicine; Oncology; Internal medicine; Clinical endpoint; PI3K/AKT/mTOR pathway; Progression-free survival; Targeted therapy; Cancer; Sunitinib; Chemotherapy; Clinical trial; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000372521,0.0002331187,0.000497961,0.0001557992,0.0001520319,0.0002834809,0.0001362638,0.0001671581,0.0006785079],"category_scores_gemma":[0.0005086947,0.00008879884,0.0002564506,0.0002095837,0.0001481314,0.0001960431,0.0001721201,0.0003632097,0.0000931422],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002890707,"about_ca_system_score_gemma":0.0003012432,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002065392,"about_ca_topic_score_gemma":0.0009595855,"domain_scores_codex":[0.9998708,0.0000465638,0.00001369518,0.00002461547,0.00002469136,0.00001961607],"domain_scores_gemma":[0.9997428,0.00006540858,0.00009024621,0.00001142759,0.00001405265,0.0000760105],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0626023,0.004125048,0.3190104,0.0005723104,0.001527702,0.002224134,0.0001939775,0.005991221,0.1568725,0.0002951956,0.003089562,0.4434957],"study_design_scores_gemma":[0.01385903,0.09488497,0.825919,0.00009787612,0.001801388,0.01245981,0.0002301589,0.007744615,0.0307377,0.0005441777,0.01167037,0.00005092508],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996973,0.001693043,0.0001625727,0.0001327296,0.000007343071,0.00004241836,0.00009385122,0.000018101,0.0008768974],"genre_scores_gemma":[0.999078,0.000302492,0.0002873241,0.00009236841,0.0000170557,0.0000180499,0.0001180949,0.000002562385,0.00008410119],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0006785079,"threshold_uncertainty_score":0.002269864,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008266148816195511,"score_gpt":0.2463326452171442,"score_spread":0.2380664964009487,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}